Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience.
| Author | |
|---|---|
| Abstract | :
Cure rates for chronic hepatitis C have improved dramatically with direct-acting antivirals (DAAs), but treatment barriers remain. We aimed to compare treatment initiation rates and barriers across both interferon-based and DAA-based eras. |
| Year of Publication | :
0
|
| Journal | :
BMJ open gastroenterology
|
| Volume | :
4
|
| Issue | :
1
|
| Number of Pages | :
e000181
|
| Date Published | :
2017
|
| URL | :
http://dx.doi.org/10.1136/bmjgast-2017-000181
|
| DOI | :
10.1136/bmjgast-2017-000181
|
| Short Title | :
BMJ Open Gastroenterol
|
| Download citation |